Le Lézard
Classified in: Covid-19 virus
Subjects: MAV, CCA

SNC-Lavalin to hold virtual annual meeting of shareholders and first quarter earnings conference call and webcast on May 14, 2021


MONTREAL, April 14, 2021 /CNW/ - SNC-Lavalin Group Inc. (TSX: SNC), a fully integrated professional services and project management company with offices around the world, will hold its virtual annual meeting of shareholders and its conference call to review results for the first quarter 2021 on May 14, 2021.

Annual Meeting of Shareholders
Again this year, as precautionary measure to proactively address the public health impact of COVID-19 and to mitigate health and safety risks to shareholders, employees and other stakeholders, the Company will hold its annual meeting of shareholders in a virtual format. SNC-Lavalin's virtual annual meeting of shareholders will be held at 11:00 a.m. Eastern Time on Friday, May 14, 2021 via live audio webcast online at https://web.lumiagm.com/439549909. Additional information of the event can also be found at https://www.snclavalin.com/en/investors/agm-2021.

Information related to the annual meeting of shareholders can also be found in SNC-Lavalin's Management Proxy Circular at https://www.snclavalin.com/en/investors/investor-essentials/investors-briefcase/2021. Shareholder participation is very important to us and we encourage shareholders to vote.

Q1 2021 Results
SNC-Lavalin will hold a conference call to review results for its first quarter 2021. The public is invited to listen to the conference call on Friday, May 14, 2021, at 1:30 p.m. Eastern Time. Participants will be Ian L. Edwards, President and Chief Executive Officer and Jeff Bell, Executive Vice-President and Chief Financial Officer. Financial results will be released prior to the market open that day.

A live audio webcast of the conference call and an accompanying slide presentation will be available at www.investors.snclavalin.com. The call will also be accessible by telephone, please dial toll free at 1 800 319 4610 in North America, or dial 1 604 638 5340 outside North America. You can also use the following numbers; 416 915 3239 in Toronto, 514 375 0364 in Montreal, or 080 8101 2791 in the United Kingdom.

A recording and a transcript of the conference call will be available on our website within 24 hours following the call.

About SNC-Lavalin
Founded in 1911, SNC-Lavalin is a fully integrated professional services and project management company with offices around the world. SNC-Lavalin connects people, technology and data to help shape and deliver world-leading concepts and projects, while offering comprehensive innovative solutions across the asset lifecycle. Our expertise is wide-ranging ? consulting & advisory, intelligent networks & cybersecurity, design & engineering, procurement, project & construction management, operations & maintenance, decommissioning and sustaining capital ? and delivered to clients in four strategic sectors: EDPM (engineering, design and project management), Infrastructure, Nuclear and Resources, supported by Capital. People. Drive. Results. www.snclavalin.com

SOURCE SNC-Lavalin


These press releases may also interest you

at 03:00
Caledonia Mining Corporation Plc ("Caledonia" or the "Company")  announces its operating and financial results for the year ended December 31, 2023 (the "Year"). Further information on the financial and operating results for the Year and the quarter...

at 00:01
In advance of the upcoming NAB 2024 show, fan-streaming trailblazer Attention Seekers announced that it has selected Eluvio to provide the back-end technology platform for its next-generation Keystream service, a private press streaming service...

27 mar 2024
The "United States Self-Monitoring Blood Glucose Devices Market Growth, Share, Size, Trends, Analysis and Forecast (2024 - 2032)" report has been added to  ResearchAndMarkets.com's offering. The latest comprehensive research study has been added to...

27 mar 2024
The "Highly Potent API Market - A Global and Regional Analysis: Focus on Type, Type of Synthesis, Therapeutic Area, Type of Manufacturing, End User, and Country - Analysis and Forecast, 2023-2033" report has been added to  ResearchAndMarkets.com's...

27 mar 2024
Akebia Therapeutics®, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the U.S. Food and Drug Administration (FDA)...

27 mar 2024
The "Green Hydrogen Market - A Global and Regional Analysis: Focus on Application, Technology, Renewable Energy Source, and Region - Analysis and Forecast, 2023-2033" report has been added to  ResearchAndMarkets.com's offering. The global green...



News published on and distributed by: